SCHEMBL11355379

SCHEMBL11355379

O=c1c2c(ncn2CC2CO2)n(CC2CO2)c(=O)n1CC1CO1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.49
▸ HBB P68871 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ KMT2A Q03164 1/20 0.48
▸ PDE4A P27815 10/20 0.43
▸ PDE4B Q07343 10/20 0.43
▸ PDE4C Q08493 10/20 0.43
▸ PDE4D Q08499 10/20 0.43
▸ ADORA2A P29274 8/20 0.43
▸ ADORA2B P29275 8/20 0.43
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11853423 0.87 PDE4A (0.51) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL9350631 0.81 PDE4A (0.51) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL9293404 0.80 KMT2A (0.74) SMN1; SMN2KMT2AADORA2B
SCHEMBL2794360 0.74 ADORA2B (0.60) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL10973640 0.73 TP53 (0.52) TP53HBBSMN1; SMN2KMT2APDE4A
SCHEMBL22521916 0.72 KMT2A (0.56) SMN1; SMN2KMT2AADORA2B
SCHEMBL9350638 0.72 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10813293 0.72 PDE4A (0.61) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL10815371 0.71 ADORA2A (0.51) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL9294204 0.71 ADORA2A (0.50) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0033503-A2 Medicaments with cytostatic activity and use of cyclic compounds, in which the heterocyclic N-ring atoms are substituted by several glycidyl groups, in pharmaceutical compositions Henkel Kommanditgesellschaft auf Aktien (DE) 1981-08-12 — — EP disclosed
Send feedback